Status:
UNKNOWN
Clinical Implication CMR in AMI Registry
Lead Sponsor:
Samsung Medical Center
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
19+ years
Brief Summary
1. To evaluate the clinical implication of cardiac magnetic resonance imaging in patients with acute myocardial infarction 2. To determine factors affecting the 6-month remodeling index assessed by ca...
Detailed Description
To date, advances in medical treatment and reperfusion therapy led to markedly decreased morbidity and mortality rate in patients with acute myocardial infarction (AMI). Nevertheless, there is a deter...
Eligibility Criteria
Inclusion
- Subjects diagnosed as type 1 myocardial infarction the presence of acute myocardial injury detected by abnormal cardiac biomarkers in the setting of evidence of acute myocardial ischemia.
Exclusion
- Patients who cannot perform cardiac magnetic resonance imaging
- Target vessel is not suitable for coronary intervention
Key Trial Info
Start Date :
March 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04788940
Start Date
March 8 2021
End Date
December 31 2024
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351